Studies on the induction of anterior chamber‐associated immune deviation (ACAID) III. Induction of ACAID depends upon intraocular transforming growth factor‐β
- 1 January 1992
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 22 (1), 165-173
- https://doi.org/10.1002/eji.1830220125
Abstract
Delayed hypersensitivity (DH), the prototypical form of cell-mediated immune responsiveness, is mediated with the participation of considerable nonspecific inflammation which necessarily disrupts the anatomic integrity of involved and adjacent tissues. Damage of this type is of minor consequence to many visceral and cutaneous organs, but is of devastating consequence for organs such as the eye and the brain. At least in the case of the eye, the organ is remarkably adept at regulating the immune system's ability to respond to intraocular antigens by selectively down-regulating both the induction and expression of delayed hypersensitivity while leaving other effector modalities intact. This ability of the eye to selectivity down-regulate systemic DH responses to intracamerally inoculated antigens is known as anterior chamber-associated immune deviation (ACAID) and is mediated in part by antigen-specific regulatory T cells. Recent work suggests that macrophages (MΦ) that reside in the iris and ciliary body can migrate out of an antigen-bearing eye and activate regulatory T cells within the spleen. In an effort to understand the mechanism by which intraocular MΦ interact with antigen in the anterior chamber of the eye (AC) and subsequently induce splenic regulatory cells in ACAID, we have investigated what role, if any, the AC microenvironment itself plays in ACAID induction. The results reveal that CD45− parenchymal iris/ciliary cells secrete a soluble factor(s) locally and into the aqueous humor which endows resident, mature MΦ with ACAID-inducing capabilities. Mice receiving infusions of these altered, antigen-pulsed MΦ are incapable of mounting a significant DH response following immunization with antigen in adjuvant. Importantly, the ACAID-inducing effect is achieved when conventional, extraocular MΦ are exposed in vitro to a soluble factor present in aqueous humor or culture SN from iris and ciliary body cells. Further investigations into the identity of this factor reveal it to be transforming growth factor-β (TGF-β). The role of TGF-β in the generation of ACAID, as well as the implications of these findings to an understanding of immunologic privilege in general, are discussed.Keywords
This publication has 36 references indexed in Scilit:
- Regulation and biological function of helminth-induced cytokine responsesImmunology Today, 1991
- The role of IL-10 in crossregulation of TH1 and TH2 responsesImmunology Today, 1991
- Could specific oral tolerance be a therapy for autoimmune disease?Immunology Today, 1990
- Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection.The Journal of Experimental Medicine, 1990
- INDUCTION OF DELAYED HYPERSENSITIVITY TO ALLOANTIGENS COINJECTED WITH LANGERHANS CELLS INTO THE ANTERIOR CHAMBER OF THE EYE ABROGATION OF ANTERIOR CHAMBER-ASSOCIATED IMMUNE DEVIATIONTransplantation, 1989
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.The Journal of Experimental Medicine, 1986
- Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth FactorScience, 1984
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981
- Impaired Cell-Mediated Immunity in Hodgkin's Disease Mediated by Suppressor Lymphocytes and MonocytesJournal of Clinical Investigation, 1978
- ORTHOTOPIC SKIN GRAFT SURVIVAL IN RATS THAT HAVE HARBORED SKIN IMPLANTS IN THE ANTERIOR CHAMBER OF THE EYETransplantation, 1977